In this study we evaluated FRα tumour expression and levels of sFRα in the circulation, with the aim of further characterising the clinico-pathologic correlates of this potential clinical biomarker, and of exploring the role of sFRα as a surrogate for tumoural FRα expression, tumour burden and response to treatment. Here, FOLR1 is linked to neoplasm.